What's Behind the Surge in Chelsea Therapeutics' (NASDAQ: CHTP) Shares?

A combination of a technical rebound and creative tail-wagging by a SeekingAlpha columnist, writing under the pseudonym ‘Trade In Mexico’, sends shares of Chelsea Therapeutics (NASDAQ: CHTP) higher by about a third, as of the 11AM mark on Friday.

Another investor argues that Chelsea would be ignorant to not raise capital on any spike in their share price. TheStreets Adam Feuerstein adds that the company’s management team is incompetent (source).

Traders could be looking for shares to fill the gap to about $1.46, though reactions from investors suggest this would be short-lived and primarily momentum-driven.